PCR-based pre-emptive therapy of cytomegalovirus infections after allogeneic stem cell transplantation with sequential intravenous ganciclovir foscarnet and oral ganciclovir.

被引：0
|
作者：
Chakrabarti, S [1 ]
Collingham, K [1 ]
Pillay, D [1 ]
Milligan, DW [1 ]
机构：
[1] Birmingham Heartlands Hosp, Birmingham B9 5ST, W Midlands, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1999年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
119
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [41] Pre-emptive therapy with valganciclovir for cytomegalovirus (CMV) infection after allogeneic haematopoietic stem cell transplantation (Allo-HSCT)
    Topcuoglu, P.
    Arslan, O.
    Ozcan, M.
    Ilhan, O.
    Akan, H.
    Uysal, A.
    Gurman, G.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S322 - S323
  • [42] Oral valganciclovir versus ganciclovir as delayed pre-emptive therapy for patients after allogeneic hematopoietic stem cell transplant: a pilot trial (04-0274) and review of the literature
    Chawla, J. S.
    Ghobadi, A.
    Mosley, J., III
    Verkruyse, L.
    Trinkaus, K.
    Abboud, C. N.
    Cashen, A. F.
    Stockerl-Goldstein, K. E.
    Uy, G. L.
    Westervelt, P.
    DiPersio, J. F.
    Vij, R.
    TRANSPLANT INFECTIOUS DISEASE, 2012, 14 (03) : 259 - 267
  • [43] Oral valganciclovir is an effective primary pre-emptive therapy of cytomegalovirus disease in recipients of allogeneic stem cell transplant
    Candoni, A.
    Mestroni, R.
    Simeone, E.
    Cerno, M.
    Fanin, R.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S175 - S176
  • [44] Oral valganciclovir as pre-emptive therapy for CMV infection post allogeneic haematopoietic stem cell transplantation
    Busca, A
    Locatelli, F
    Ceretto, C
    Ghisetti, V
    de Fabritiis, P
    Mirabile, M
    Gentile, G
    Falda, M
    BONE MARROW TRANSPLANTATION, 2006, 37 : S188 - S188
  • [45] High-dose acyclovir and pre-emptive ganciclovir in prevention of cytomegalovirus disease in pediatric patients following peripheral blood stem cell transplantation
    V Hazar
    S Kansoy
    A Küpesiz
    S Aksoylar
    M Kantar
    A Yeşilipek
    Bone Marrow Transplantation, 2004, 33 : 931 - 935
  • [46] High-dose acyclovir and pre-emptive ganciclovir in prevention of cytomegalovirus disease in pediatric patients following peripheral blood stem cell transplantation
    Hazar, V
    Kansoy, S
    Küpesiz, A
    Aksoylar, S
    Kantar, M
    Yesilipek, A
    BONE MARROW TRANSPLANTATION, 2004, 33 (09) : 931 - 935
  • [47] Qualitative plasma PCR (AMPLICOR CMV) vs pp65 antigenemia (AG) for monitoring active cytomegalovirus (CMV) infection and pre-emptive ganciclovir therapy after allogeneic peripheral blood stem cell transplantation (Allo-PBT).
    Solano, C
    Gutierrez, A
    Munoz, I
    Navarro, D
    Garcia-Clavel, B
    Teruel, I
    Gomez, C
    Gimeno, C
    Garcia-Conde, J
    BLOOD, 2001, 98 (11) : 394A - 394A
  • [48] Letermovir Prophylaxis Versus Pre-Emptive Therapy for Cytomegalovirus after Hematopoietic Stem-Cell Transplantation
    Gabrielli, Giulia
    Faraci, Danilo Giuseppe Giuseppe
    Martin, Aurora
    Lia, Giuseppe
    Butera, Sara
    Dogliotti, Irene
    Marco, Cerrano
    Dellacasa, Giovannino Cic Maria
    Busca, Alessandro
    Bruno, Benedetto
    Giaccone, Luisa
    BLOOD, 2021, 138
  • [49] Initial experience with oral valganciclovir for pre-emptive cytomegalovirus therapy after lung transplantation
    Aigner, C
    Jaksch, P
    Winkler, G
    Czebe, K
    Taghavi, S
    Marta, G
    Klepetko, W
    WIENER KLINISCHE WOCHENSCHRIFT, 2005, 117 (13-14) : 480 - 484
  • [50] Efficacy and toxicity of ganciclovir and foscarnet combination therapy for refractory Cytomegalovirus reactivation in adult allogeneic stem cell transplant recipients
    Kohlschmidt, Melanie
    Christopeit, Maximilian
    Wolschke, Christine
    Ayuk, Francis
    Kroger, Nicolaus
    Langebrake, Claudia
    BONE MARROW TRANSPLANTATION, 2018, 53 : 555 - 556
12345